Irina Rivkind Koffler
Stock Analyst at Mizuho
(0)
# 4639
Out of 5,293 analysts
84
Total ratings
31.25%
Success rate
-20.08%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
EOLS Evolus | Assumes: Buy | 30 | 11.96 | 150.84% | 4 | Sep 5, 2019 | |
AGN Allergan | Downgrades: Neutral | 171 188 | n/a | n/a | 8 | Jun 26, 2019 | |
DERM Journey Medical | Upgrades: Buy | 17 14 | 5.97 | 134.51% | 4 | Jun 6, 2019 | |
JAZZ Jazz Pharmaceuticals | Maintains: Neutral | 146 148 | 126.2 | 17.27% | 6 | May 8, 2019 | |
PCRX Pacira BioSciences | Upgrades: Neutral | 29 38 | 24.56 | 54.72% | 4 | May 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 40 41 | 1.55 | 2545.16% | 7 | Mar 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 11 5 | n/a | n/a | 3 | Mar 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 29 22 | n/a | n/a | 3 | Dec 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 61 63 | 32.19 | 95.71% | 2 | Dec 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 21 | n/a | n/a | 6 | Nov 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 28 29 | 15.27 | 89.91% | 7 | Sep 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 9 | May 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 3 | May 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 7 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 17 0 | n/a | n/a | 6 | Dec 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 5 | Oct 3, 2017 |